[go: up one dir, main page]

IT1176916B - Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica - Google Patents

Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica

Info

Publication number
IT1176916B
IT1176916B IT23086/84A IT2308684A IT1176916B IT 1176916 B IT1176916 B IT 1176916B IT 23086/84 A IT23086/84 A IT 23086/84A IT 2308684 A IT2308684 A IT 2308684A IT 1176916 B IT1176916 B IT 1176916B
Authority
IT
Italy
Prior art keywords
pharmaceutical
thrombotic
dietetic composition
arteriosclerotic
composition
Prior art date
Application number
IT23086/84A
Other languages
English (en)
Other versions
IT8423086A1 (it
IT8423086A0 (it
Inventor
Elvira Pistolesi
Original Assignee
Elvira Pistolesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11203625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1176916(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elvira Pistolesi filed Critical Elvira Pistolesi
Priority to IT23086/84A priority Critical patent/IT1176916B/it
Publication of IT8423086A0 publication Critical patent/IT8423086A0/it
Priority to EP85112675A priority patent/EP0180786B2/en
Priority to AT85112675T priority patent/ATE43242T1/de
Priority to DE8585112675T priority patent/DE3570362D1/de
Priority to JP60225953A priority patent/JPS61112020A/ja
Publication of IT8423086A1 publication Critical patent/IT8423086A1/it
Priority to US07/027,036 priority patent/US4780456A/en
Application granted granted Critical
Publication of IT1176916B publication Critical patent/IT1176916B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT23086/84A 1984-10-10 1984-10-10 Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica IT1176916B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT23086/84A IT1176916B (it) 1984-10-10 1984-10-10 Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
EP85112675A EP0180786B2 (en) 1984-10-10 1985-10-07 Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
AT85112675T ATE43242T1 (de) 1984-10-10 1985-10-07 Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
DE8585112675T DE3570362D1 (en) 1984-10-10 1985-10-07 Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
JP60225953A JPS61112020A (ja) 1984-10-10 1985-10-09 抗血栓性並びに抗動脈硬化性高活性を有する薬剤的又は栄養的組成物
US07/027,036 US4780456A (en) 1984-10-10 1987-03-20 Pharmaceutical or dietetic composition having a high antiarteriosclerotic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23086/84A IT1176916B (it) 1984-10-10 1984-10-10 Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica

Publications (3)

Publication Number Publication Date
IT8423086A0 IT8423086A0 (it) 1984-10-10
IT8423086A1 IT8423086A1 (it) 1986-04-10
IT1176916B true IT1176916B (it) 1987-08-18

Family

ID=11203625

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23086/84A IT1176916B (it) 1984-10-10 1984-10-10 Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica

Country Status (6)

Country Link
US (1) US4780456A (it)
EP (1) EP0180786B2 (it)
JP (1) JPS61112020A (it)
AT (1) ATE43242T1 (it)
DE (1) DE3570362D1 (it)
IT (1) IT1176916B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6284028A (ja) * 1985-07-26 1987-04-17 イエダ・リサ−チ・アンド・デイベロツプメント・カンパニ−・リミテツド 膜流動化のための脂質混合物
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
NO157302C (no) * 1985-12-19 1988-02-24 Norsk Hydro As Fremgangsmaate for fremstilling av et fiskeoljekonsentrat.
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
IT1205043B (it) * 1987-05-28 1989-03-10 Innova Di Ridolfi Flora & C S Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e dietetiche contenenti detti esteri
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
DE3920679A1 (de) * 1989-06-23 1991-01-10 Milupa Ag Fettmischung zur herstellung von nahrungen, insbesondere saeuglingsnahrungen
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
DE69231793T2 (de) * 1991-01-24 2001-11-08 Martek Corp., Columbia Mikrobielle öle und ihre verwendungen
FR2673513B1 (fr) * 1991-03-05 1993-10-29 Institut Recherche Biologique Sa Nouvelles compositions dietetiques a base de lipides phosphoryles et leur utilisation dans l'amelioration des troubles de la vision.
GB9125602D0 (en) * 1991-12-02 1992-01-29 Efamol Holdings Method of preventing reocclusion of arteries
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
JP2711064B2 (ja) * 1993-11-09 1998-02-10 マリーンバイオ株式会社 健康食品
FR2758055B1 (fr) * 1997-01-06 1999-02-26 Sea Oil Poudre formee de microcapsules a base d'huile de poisson riche en acides gras polyinsatures
FR2761887B1 (fr) * 1997-04-11 1999-06-18 Roland Asmar Medicament visant a la prevention multifactorielle des maladies cardiovasculaires
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6312703B1 (en) 1998-02-06 2001-11-06 Lecigel, Llc Compressed lecithin preparations
HU227182B1 (en) 2000-03-06 2010-09-28 Andras Javor Lecitin-ascorbic acid combination
US6733797B1 (en) 2000-11-15 2004-05-11 William K. Summers Neuroceutical for improving memory and cognitive abilities
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
US6683066B2 (en) * 2001-09-24 2004-01-27 Yanming Wang Composition and treatment method for brain and spinal cord injuries
TWI365716B (en) * 2003-12-02 2012-06-11 Suntory Holdings Ltd Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
JP5504405B2 (ja) * 2005-06-10 2014-05-28 国立大学法人山口大学 血管病予防に効果を有する食品組成物
BRPI0614981A2 (pt) * 2005-08-16 2011-04-26 Alan L Buchman uso de colina para prevenção de trombose associada com a nutrição parenteral total
PL2046312T3 (pl) * 2006-07-14 2021-02-08 Kaydence Pharma As Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2
WO2008093848A1 (ja) * 2007-02-02 2008-08-07 Sunstar Inc. ホスファチジルコリンを含有する炎症マーカー低減組成物
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10183053B1 (en) 2017-06-19 2019-01-22 Gene S. Rosen Multi-component formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4252793A (en) * 1979-06-18 1981-02-24 American Lecithin Company Injectable lecithin preparation
DE3028074C2 (de) * 1980-07-22 1983-12-08 Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg Verfahren zur Herstellung eines lecithinhaltigen Produktes
DE3230103A1 (de) * 1982-08-13 1984-02-16 Mletzko, Armin von, Dr., 4520 Melle Diaetetikum
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
EP0148303B1 (de) * 1984-01-11 1988-04-06 von Mletzko, Armin, Dr. Diätetikum

Also Published As

Publication number Publication date
US4780456A (en) 1988-10-25
IT8423086A1 (it) 1986-04-10
IT8423086A0 (it) 1984-10-10
ATE43242T1 (de) 1989-06-15
DE3570362D1 (en) 1989-06-29
JPS61112020A (ja) 1986-05-30
EP0180786B2 (en) 1996-04-03
EP0180786B1 (en) 1989-05-24
EP0180786A1 (en) 1986-05-14

Similar Documents

Publication Publication Date Title
IT1176916B (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US5562913A (en) Formulation for use in smokers
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
HUP0002701A1 (hu) Esszenciális zsírsavakat és bioaktív diszulfidokat tartalmazó gyógyhatású és dietikus készítmények
ATE87825T1 (de) Zusammensetzungen essentieller fettsaeuren.
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
ATE88631T1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
ATE212194T1 (de) Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
DE3261761D1 (en) Pharmaceutical and dietary composition when used for enhancement of 1-series pg production
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
ATE86108T1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
ES2009248A6 (es) Composicion dietetica a base de algas que contengan selenio.
NO932984L (no) Fettsyrebehandling
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
DE3569469D1 (en) Use of phytosterolglycosides for the preparation of medicaments for treatment of elevated 5(6)alpha-epoxycholesterol levels
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19951030